An ocular composition consisting of purified water, PEG-80 sorbitan laurate, sodium trideceth sulfate, PEG-150 distearate, sodium lauroamphoacetate, cocamidopropyl hydroxysultaine, sodium chloride, PEG-15 cocopolyamine, polyhexamethylene biguanide, 1,2 hexanediol, and caprylyl glycol. The composition can be applied to a fabric pad for use as an eyelid cleanser, where the fabric pad is pre-moistened with the composition and packaged for use. The composition may also be used in an eyelid treatment kit for convenient combination treatments to improve overall eyelid hygiene and adjunctive eyelid therapy.
A composition for treating dry skin includes therapeutically active concentrations of one or more skin protecting lipids in an oleaginous base. The skin protecting lipids can include a sphingolipid and at least one oil. The composition is intended for application on the skin surrounding the eyes. The composition is configured to form a protective, occlusive layer that can moisturize the skin and reduce inflammation and itching without stinging, burning, or stripping the skin. According to an exemplary embodiment, the composition is formulated as a high viscosity ointment or gel.
A topical formulation, comprising: an ointment base; and a mixture of active pharmaceutical ingredients (APIs) contained in the ointment base, the mixture of APIs consisting of: Metronidazole; Ivermectin; and Melaleuca alternifolia (tea tree) oil. The APIs are about 0.12%-6% w/w and the ointment base is about 94% to 99% w/w of the topical formulation. The formulation can further include enhancers for the APIs, such as, moisturizers and anti-oxidants. The formulation is configured as an anti-parasitic, anti-inflammatory and anti-microbial formulation.
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
A dry eye composition containing hypochlorous acid and a demulcent. The demulcent can be polyvinylpyrrolidoe with a molecular weight of 30-50 kDa. The composition can be applied to the surface of the eye with a dropper device or a spray dispenser. Critically, hypochlorous acid is stable in the dry eye composition and maintains its effectiveness at preventing microbial growth.
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
A61K 9/00 - Medicinal preparations characterised by special physical form
The present invention illustrates formulations designed to deliver active ingredients effectively to the surface of the skin. The formulations comprise therapeutically effective amounts of antihistamine, anti-inflammatory, anesthetic, antioxidant, and anti-eczema active agents. Additional ingredients are included to enhance delivery, stability, and physiological compatibility with the skin. The topical formulations are further configured to be delivered via an applicator to the skin.
A medicated eyelid cleansing composition comprising a medicated scrub composition and an eyelid cleansing composition. The medicated scrub composition has one or more antibacterial and anti-inflammatory agents, including azithromycin and diclofenac sodium or dexamethasone phosphate. The medicated scrub composition can further include a combination of metronidazole and ivermectin. The composition is optimized for physiological compatibility and can be combined with a suitable substrate for use as a medicated eyelid cleanser.
The present invention illustrates formulations designed to deliver active ingredients effectively to the surface of the skin. The formulations comprise therapeutically effective amounts of antihistamine, anti-inflammatory, anesthetic, antioxidant, and anti-eczema active agents. Additional ingredients are included to enhance delivery, stability, and physiological compatibility with the skin. The topical formulations are further configured to be delivered via an applicator to the skin.
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
A61K 47/32 - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A medicated eyelid cleansing composition comprising a medicated scrub composition and an eyelid cleansing composition. The medicated scrub composition has one or more antibacterial and anti-inflammatory agents, including azithromycin and diclofenac sodium or dexamethasone phosphate. The medicated scrub composition can further include a combination of metronidazole and ivermectin. The composition is optimized for physiological compatibility and can be combined with a suitable substrate for use as a medicated eyelid cleanser.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/196 - Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K 31/4172 - Imidazole-alkanecarboxylic acids, e.g. histidine
A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical compositions for the skin and skin structures
surrounding the eyes and pharmaceutical compositions for the
skin and skin structures surrounding the eyes and swab
sticks for human medical use sold as a kit.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Pharmaceutical compositions for the treatment of eye diseases and conditions; kits comprising pharmaceutical compositions for the treatment of eye diseases and conditions and swab sticks for human medical use.
An antimicrobial eyelid cleanser composition contains hypochlorous acid, sodium acetate and purified water. The composition has a free available chlorine (FAC) concentration of from about 10 ppm-300 ppm, an osmolality of 40-200 mOsm/kg and a viscosity of 1 cP-500 cP. The composition has a pH from about 3.5-6.5. The eyelid cleanser composition is an ophthalmic or ocular composition that can clean the eyelids and eyes and remove excessive oil, debris, and desquamated skin from the eyelids and surrounding areas while reducing inflammation and promoting wound healing.
An antimicrobial eyelid cleanser composition contains hypochlorous acid, sodium acetate and purified water. The composition has a free available chlorine (FAC) concentration of from about 10 ppm - 300 ppm, an osmolality of 40-200 mOsm/kg and a viscosity of 1 cP - 500 cP. The composition has a pH from about 3.5 - 6.5. The eyelid cleanser composition is an ophthalmic or ocular composition that can clean the eyelids and eyes and remove excessive oil, debris, and desquamated skin from the eyelids and surrounding areas while reducing inflammation and promoting wound healing.
An anti -allergenic product having: at least 0.01% w/w of a plant extract, wherein the plant extract is selected from the group consisting of Camellia sinensis leaf extract, Melaleuca alternifolia leaf oil, and mixtures thereof; an amphiphilic preservative, and a glycolipid. The eyelid cleansing composition is configured to relieve redness, discomfort and irritation in and around the eyelid.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for the skin and skin structures surrounding the eyes; Kits comprising pharmaceutical preparations for the care of skin and skin structures surrounding the eyes and swabs sticks for human medical use sold together
An anti-allergenic product having: at least 0.01% w/w of a plant extract, wherein the plant extract is selected from the group consisting of Camellia sinensis leaf extract, Melaleuca alternifolia leaf oil, and mixtures thereof; an amphiphilic preservative, and a glycolipid. The eyelid cleansing composition is configured to relieve redness, discomfort and irritation in and around the eyelid.
Anon-irritating topical composition for moisturizing and cleansing the skin includes: a mixture of moisturizers and conditioning agents; a mixture of surfactants; a mixture of anti-irritant agents; and a mixture of hydrating and rejuvenation agents, in an aqueous vehicle. At least one ingredient in each of the ingredient groups consisting of moisturizers and conditioning agents, surfactants, anti-irritant agents, and hydrating and rejuvenation agents is plant-derived. The composition is essentially free from any synthetic additives or by-products. The composition has a pH in the range of 5.0-8.0.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
23.
CLEANSING, MOISTURIZING AND NON-IRRITATING TOPICAL COMPOSITIONS
Anon-irritating topical composition for moisturizing and cleansing the skin includes: a mixture of moisturizers and conditioning agents; a mixture of surfactants; a mixture of anti-irritant agents; and a mixture of hydrating and rejuvenation agents, in an aqueous vehicle. At least one ingredient in each of the ingredient groups consisting of moisturizers and conditioning agents, surfactants, anti-irritant agents, and hydrating and rejuvenation agents is plant-derived. The composition is essentially free from any synthetic additives or by-products. The composition has a pH in the range of 5.0-8.0.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
24.
Cleansing, moisturizing and non-irritating topical compositions
A non-irritating topical composition for moisturizing and cleansing the skin includes: a mixture of moisturizers and conditioning agents; a mixture of surfactants; a mixture of anti-irritant agents; and a mixture of hydrating and rejuvenation agents, in an aqueous vehicle. At least one ingredient in each of the ingredient groups consisting of moisturizers and conditioning agents, surfactants, anti-irritant agents, and hydrating and rejuvenation agents is plant-derived. The composition is essentially free from any synthetic additives or by-products. The composition has a pH in the range of 5.0-8.0.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 8/99 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A composition for treating dry skin includes therapeutically active concentrations of one or more skin protecting lipids in an oleaginous base. The skin protecting lipids can include a sphingolipid and at least one oil. The composition is intended for application on the skin surrounding the eyes. The composition is configured to form a protective, occlusive layer that can moisturize the skin and reduce inflammation and itching without stinging, burning, or stripping the skin. According to an exemplary embodiment, the composition is formulated as a high viscosity ointment or gel.
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A composition for treating dry skin includes therapeutically active concentrations of one or more skin protecting lipids in an oleaginous base. The skin protecting lipids can include a sphingolipid and at least one oil. The composition is intended for application on the skin surrounding the eyes. The composition is configured to form a protective, occlusive layer that can moisturize the skin and reduce inflammation and itching without stinging, burning, or stripping the skin. According to an exemplary embodiment, the composition is formulated as a high viscosity ointment or gel.
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A composition for treating dry skin includes therapeutically active concentrations of one or more skin protecting lipids in an oleaginous base. The skin protecting lipids can include a sphingolipid and at least one oil. The composition is intended for application on the skin surrounding the eyes. The composition is configured to form a protective, occlusive layer that can moisturize the skin and reduce inflammation and itching without stinging, burning, or stripping the skin. According to an exemplary embodiment, the composition is formulated as a high viscosity ointment or gel.
A topical skin moisturizing composition comprising: (a) one or more phospholipids; (b) a plurality of demulcents; (c) one or more polymeric moisturizing agents; (d) one or more preservatives; (e) one or more vitamins; and (f) an aqueous vehicle. The moisturizing composition can have an osmolality in the range of 80 mOsm/kg to 500 mOsm/kg. The composition is configured for use on the face and, particularly for application on and around the delicate eye area including the eyelids.
A topical skin moisturizing composition comprising: (a) one or more phospholipids; (b) a plurality of demulcents; (c) one or more polymeric moisturizing agents; (d) one or more preservatives; (e) one or more vitamins; and (f) an aqueous vehicle. The moisturizing composition can have an osmolality in the range of 80 mOsm/kg to 500 mOsm/kg. The composition is configured for use on the face and, particularly for application on and around the delicate eye area including the eyelids.
A topical skin moisturizing composition comprising: (a) one or more phospholipids; (b) a plurality of demulcents; (c) one or more polymeric moisturizing agents; (d) one or more preservatives; (e) one or more vitamins; and (f) an aqueous vehicle. The moisturizing composition can have an osmolality in the range of 80 mOsm/kg to 500 mOsm/kg. The composition is configured for use on the face and, particularly for application on and around the delicate eye area including the eyelids.
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
(1) Skin cleansers for use on eyelids; pre-moistened pads and eyelid wipes, namely non-medicated eyelid wipes; non-medicated skin care preparations, namely, cleaners, and foaming wash
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Eyelid cleansers; cosmetics and cosmetic preparations for the eyes; cosmetic preparations for skin care around the eyelids; cosmetic preparations for eyelid skin care
(2) Pharmaceutical preparations for the treatment of eye diseases and conditions; anti-bacterial eye cleansers; anti-inflammatory eye cleansers; medicated skin care preparations around the eyelids for the treatment of eye diseases and conditions; medicated skin care preparations for the treatment of eyelid skin disorders.
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Eyelid cleansers; cosmetics and cosmetic preparations for the eyes; cosmetic preparations for skin care around the eyelids; cosmetic preparations for eyelid skin care. Pharmaceutical preparations for the treatment of eye diseases and conditions; anti-bacterial eye cleansers; anti-inflammatory eye cleansers; medicated skin care preparations around the eyelids; medicated skin care preparations for the eyelids.
The invention involves forceps having rounded grasping tips. The rounded tips are configured to avoid puncturing an amniotic membrane during insertion over an ocular surface for the treatment of dry eye disease and inflammation of the eyes and to avoid injuring the conjunctiva during removal of an amniotic membrane from the ocular surface. The forceps have grasping tips at its distal end, wherein one of the grasping tips has a notch on its inside surface. The dimensions of the notch are configured to permit an eye doctor to securely and safely grasp a lip of an amniotic membrane insert for better insertion and removal from an ocular surface.
An antimicrobial eyelid cleanser composition contains: (a) a hypohalous acid; (b) one or more surfactants having a HLB value of 5 to 18; and (c) an aqueous vehicle, the aqueous vehicle comprising: (i) one or more tonicity adjusters; (ii) one or more osmolality adjusters for adjusting an osmolality of the composition; and (iii) one or more pH adjusters for maintaining the pH of the composition at between about 4.5 to about 8.0. The composition can be dispensed in a foam, liquid, spray, mist, gel or lotion form. The composition can facilitate long term eyelid hygiene by removing excess oil, debris and desquamated skin and provide relief for inflammation of the eyes.
A61K 8/02 - Cosmetics or similar toiletry preparations characterised by special physical form
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
A first ocular treatment kit comprises one or more sealed wrappers containing an applicator and a first ocular composition. The applicator includes a shaft and a swab, wherein the swab is coupled to a first end of the shaft. The swab is saturated with the first ocular composition inside the wrapper. The first ocular composition comprises polyaminopropyl biguanide, 1,2 hexanediol and caprylyl glycol. A second ocular treatment kit comprises a first sealed wrapper and a second sealed wrapper. The first sealed wrapper contains an applicator while the second sealed wrapper contains a second ocular composition. The second ocular composition comprises tea tree oil, tea tree oil, sea buckthorn oil and a medium chain triglyceride.
A61H 35/02 - Baths for specific parts of the body, e.g. breast douches for the eyes
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
41.
ANTI-ALLERGENIC OCULAR COMPOSITIONS AND EYELID CLEANSING WIPES
An anti-allergenic product consists of: (A) a substrate; and (B) an eyelid cleansing composition comprising: at least 0.01% w/w of a plant extract, wherein the plant extract is selected from the group consisting of Camellia sinensis leaf extract, Melaleuca alternifolia leaf oil, and mixtures thereof; and phytosphingosine hydrochloride. The substrate can be pre-moistened with the composition. The eyelid cleansing composition is configured to relieve redness, discomfort and irritation in and around the eyelid.
41 - Education, entertainment, sporting and cultural services
Goods & Services
Educational services, namely, providing online non-downloadable videos featuring information, interviews, and programs in the fields of eye health; entertainment services, namely, providing online non-downloadable videos featuring information, interviews, and programs on eye health broadcast via the Internet and other social media platforms
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
10 - Medical apparatus and instruments
Goods & Services
Eye masks featuring heat-diffusing properties worn to
moisturize eyes and areas of the face around the eyes;
facial masks for the eyes featuring heat-diffusing
properties worn to moisturize eyes and areas of the face
around the eyes. Therapeutic eye masks featuring heat-diffusing properties
worn to soothe and relieve symptoms associated with dry eye.
Medical devices for use by eye care professionals in treating eye diseases and conditions by applying heat and very gentle pressure to the eyelids; medical devices for applying heat and gentle pressure to the eyelids; medical devices, and parts and components therefor, for diagnosing, treating, and monitoring dry eyes and meibomian gland dysfunction by applying heat and very gentle pressure to the eyelids.
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
10 - Medical apparatus and instruments
Goods & Services
(1) Eye masks featuring heat-diffusing properties worn to moisturize eyes and areas of the face around the eyes; facial masks for the eyes featuring heat-diffusing properties worn to moisturize eyes and areas of the face around the eyes.
(2) Therapeutic eye masks featuring heat-diffusing properties worn to soothe and relieve symptoms associated with dry eye.
Cocos nucifera (coconut oil); hydrolyzed glycosaminoglycans; and caprylic/capric triglycerides. The plurality of vitamins is selected from a group consisting of vitamin C, vitamin E, salts/derivatives of vitamin C and vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins includes: sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 31/166 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 36/889 - Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
A61K 31/665 - Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
A61K 36/886 - Aloeaceae (Aloe family), e.g. aloe vera
A61K 36/58 - Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
The invention relates to an eye mask for treating dry eyes and other eye conditions related to blepharitis or meibomian gland dysfunction. The eye mask acts as a warm compress which ensures the eyelids are heated to expedite eyelid expression to balance out the tear film and treat dry eyes. In one embodiment, an eye mask for treating an ocular condition includes: a fabric having a first layer and a second layer opposite the first layer; and a heat diffusing fill material enclosed between the first and the second layers. The first layer and the second layer are stitched together substantially along their edges. The fill material is configured to deliver a moist heat to an ocular surface.
The invention relates to an eye mask for treating dry eyes and other eye conditions related to blepharitis or meibomian gland dysfunction. The eye mask acts as a warm compress which ensures the eyelids are heated to expedite eyelid expression to balance out the tear film and treat dry eyes. In one embodiment, an eye mask for treating an ocular condition includes: a fabric having a first layer and a second layer opposite the first layer; and a heat diffusing fill material enclosed between the first and the second layers. The first layer and the second layer are stitched together substantially along their edges. The fill material is configured to deliver a moist heat to an ocular surface.
The invention relates to an eye mask for treating dry eyes and other eye conditions related to blepharitis or meibomian gland dysfunction. The eye mask acts as a warm compress which ensures the eyelids are heated to expedite eyelid expression to balance out the tear film and treat dry eyes. In one embodiment, an eye mask for treating an ocular condition includes: a fabric having a first layer and a second layer opposite the first layer; and a heat diffusing fill material enclosed between the first and the second layers. The first layer and the second layer are stitched together substantially along their edges. The fill material is configured to deliver a moist heat to an ocular surface.
The invention involves forceps having rounded grasping tips. The rounded tips are configured to avoid puncturing an amniotic membrane during insertion over an ocular surface for the treatment of dry eye disease and inflammation of the eyes and to avoid injuring the conjunctiva during removal of an amniotic membrane from the ocular surface. The forceps have grasping tips at its distal end, wherein one of the grasping tips has a notch on its inside surface. The dimensions of the notch are configured to permit an eye doctor to securely and safely grasp a lip of an amniotic membrane insert for better insertion and removal from an ocular surface.
The invention involves forceps having rounded grasping tips. The rounded tips are configured to avoid puncturing an amniotic membrane during insertion over an ocular surface for the treatment of dry eye disease and inflammation of the eyes and to avoid injuring the conjunctiva during removal of an amniotic membrane from the ocular surface. The forceps have grasping tips at its distal end, wherein one of the grasping tips has a notch on its inside surface. The dimensions of the notch are configured to permit an eye doctor to securely and safely grasp a lip of an amniotic membrane insert for better insertion and removal from an ocular surface.
The invention involves forceps having rounded grasping tips. The rounded tips are configured to avoid puncturing an amniotic membrane during insertion over an ocular surface for the treatment of dry eye disease and inflammation of the eyes and to avoid injuring the conjunctiva during removal of an amniotic membrane from the ocular surface. The forceps have grasping tips at its distal end, wherein one of the grasping tips has a notch on its inside surface. The dimensions of the notch are configured to permit an eye doctor to securely and safely grasp a lip of an amniotic membrane insert for better insertion and removal from an ocular surface.
Medical devices for use by eye care professionals in
treating eye diseases and conditions by applying heat and
very gentle pressure to the eyelids; medical devices for
applying heat and gentle pressure to the eyelids; medical
devices, and parts and components therefor, for diagnosing,
treating, and monitoring dry eyes and meibomian gland
dysfunction by applying heat and very gentle pressure to the
eyelids.
In one form, a projection frame eyelid heater includes a heating element and a frame. The heating element has first and second heat producing areas separated by a distance corresponding to a separation of human eyes and has first and second ends. The heating element produces heat in response to an application of a voltage thereto. The frame includes a left temple attachment portion and a right temple attachment portion each having a respective back portion extending downward and inward, a left eyelid chassis portion, an intermediate chassis portion, and a right eyelid chassis portion, wherein the intermediate chassis portion connects the left eyelid chassis portion and the right eyelid chassis portion. Each of the left eyelid chassis portion and the right eyelid chassis portion is adjustable with respect to the intermediate chassis portion in a direction from the user's nose toward the user's left and right eyes, respectively.
An anti-allergenic composition comprising from about 0.01% to about 50% by weight of a polyphenol, from about 0.01% to about 50% by weight of a terpene compound, and from about 0.001% to about 10% by weight of a glycolipid. The polyphenol has a flavanol derivative. The terpene compound can be selected from the group consisting of a terpene, terpinene, a terpene derivative and combinations thereof. In an embodiment, the sphingolipid comprises about 0.2% phytosphingosine.
An anti-allergenic composition comprising from about 0.01% to about 50% by weight of a polyphenol, from about 0.01% to about 50% by weight of a terpene compound, and from about 0.001% to about 10% by weight of a glycolipid. The polyphenol has a flavanol derivative. The terpene compound can be selected from the group consisting of a terpene, terpinene, a terpene derivative and combinations thereof. In an embodiment, the sphingolipid comprises about 0.2% phytosphingosine.
(1) Medical devices for use by eye care professionals in treating eye diseases and conditions by applying heat and very gentle pressure to the eyelids; medical devices for applying heat and gentle pressure to the eyelids; medical devices, and parts and components therefor, for diagnosing, treating, and monitoring dry eyes and meibomian gland dysfunction by applying heat and very gentle pressure to the eyelids.
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
10 - Medical apparatus and instruments
Goods & Services
Eye masks featuring heat-diffusing properties worn to moisturize eyes and areas of the face around the eyes; Facial masks for the eyes featuring heat-diffusing properties worn to moisturize eyes and areas of the face around the eyes Therapeutic eye masks featuring heat-diffusing properties worn to soothe and relieve symptoms associated with dry eye
An antimicrobial eyelid cleanser composition contains: (a) a hypohalous acid; (b) one or more surfactants having a HLB value of 5 to 18; and (c) an aqueous vehicle, the aqueous vehicle comprising: (i) one or more tonicity adjusters; (ii) one or more osmolality adjusters for adjusting an osmolality of the composition; and (iii) one or more pH adjusters for maintaining the pH of the composition at between about 4.5 to about 8.0. The composition can be dispensed in a foam, liquid, spray, mist, gel or lotion form. The composition can facilitate long term eyelid hygiene by removing excess oil, debris and desquamated skin and provide relief for inflammation of the eyes.
An antimicrobial eyelid cleanser composition contains: (a) a hypohalous acid; (b) one or more surfactants having a HLB value of 5 to 18; and (c) an aqueous vehicle, the aqueous vehicle comprising: (i) one or more tonicity adjusters; (ii) one or more osmolality adjusters for adjusting an osmolality of the composition; and (iii) one or more pH adjusters for maintaining the pH of the composition at between about 4.5 to about 8.0. The composition can be dispensed in a foam, liquid, spray, mist, gel or lotion form. The composition can facilitate long term eyelid hygiene by removing excess oil, debris and desquamated skin and provide relief for inflammation of the eyes.
A61K 8/02 - Cosmetics or similar toiletry preparations characterised by special physical form
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
An antimicrobial eyelid cleanser composition contains: (a) a hypohalous acid; (b) one or more surfactants having a HLB value of 5 to 18; and (c) an aqueous vehicle, the aqueous vehicle comprising: (i) one or more tonicity adjusters; (ii) one or more osmolality adjusters for adjusting an osmolality of the composition; and (iii) one or more pH adjusters for maintaining the pH of the composition at between about 4.5 to about 8.0. The composition can be dispensed in a foam, liquid, spray, mist, gel or lotion form. The composition can facilitate long term eyelid hygiene by removing excess oil, debris and desquamated skin and provide relief for inflammation of the eyes.
Compositions and methods for treating skin redness. According to an embodiment, the invention is a topical skin care composition having a dermatologically acceptable vehicle, such as, water and a plurality of ingredients dissolved in the vehicle. The ingredients include: a blend of natural oils; a plurality of vitamins; and 0.1 - 1 wt% salicyloyl phytosphingosine. The composition is unsuitable for application on the eyelids or eye area. The blend of natural oils includes: aloe barbadensis leaf juice extract; cocos nucifera (coconut oil); hydrolyzed glycosaminoglycans; and caprylic/capric triglycerides. The plurality of vitamins is selected from a group consisting of vitamin C, vitamin E, salts/derivatives of vitamin C and vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins includes: sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil.
Compositions and methods for treating skin redness. According to an embodiment, the invention is a topical skin care composition having a dermatologically acceptable vehicle, such as, water and a plurality of ingredients dissolved in the vehicle. The ingredients include: a blend of natural oils; a plurality of vitamins; and 0.1 - 1 wt% salicyloyl phytosphingosine. The composition is unsuitable for application on the eyelids or eye area. The blend of natural oils includes: aloe barbadensis leaf juice extract; cocos nucifera (coconut oil); hydrolyzed glycosaminoglycans; and caprylic/capric triglycerides. The plurality of vitamins is selected from a group consisting of vitamin C, vitamin E, salts/derivatives of vitamin C and vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins includes: sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil.
Compositions and methods for treating skin redness. According to an embodiment, the invention is a topical skin care composition having a dermatologically acceptable vehicle, such as, water and a plurality of ingredients dissolved in the vehicle. The ingredients include: a blend of natural oils; a plurality of vitamins; and 0.1-1 wt % salicyloyl phytosphingosine. The composition is unsuitable for application on the eyelids or eye area. The blend of natural oils includes: aloe barbadensis leaf juice extract; cocos nucifera (coconut oil); hydrolyzed glycosaminoglycans; and caprylic/capric triglycerides. The plurality of vitamins is selected from a group consisting of vitamin C, vitamin E, salts/derivatives of vitamin C and vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins includes: sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 31/166 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K 36/889 - Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
A61K 31/665 - Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
A61K 36/886 - Aloeaceae (Aloe family), e.g. aloe vera
A61K 36/58 - Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
Medical devices for use by eye care professionals in treating eye diseases and conditions by applying heat and very gentle pressure to the eyelids; medical devices for applying heat and gentle pressure to the eyelids; medical devices, and parts and components therefor, for treating dry eyes and meibomian gland dysfunction by applying heat and very gentle pressure to the eyelids
Medical devices for use by eye care professionals in treating eye diseases and conditions by applying heat and very gentle pressure to the eyelids; medical devices for applying heat and gentle pressure to the eyelids; medical devices, and parts and components therefor, for diagnosing, treating, and monitoring dry eyes and meibomian gland dysfunction by applying heat and very gentle pressure to the eyelids
Systems, methods, and kits useful for cleansing the eyelids and maintaining eyelid hygiene are disclosed. In one embodiment, a system for treating or cleansing an ocular region is disclosed. The system consists essentially of: (A) a tubular applicator, wherein the applicator comprises: (i) a first chamber and a second chamber; and (ii) a sealable element situated between the first chamber and the second chamber, wherein at least the second chamber is substantially pre-filled with an ocular composition, and (B) a dispenser, wherein the dispenser is bonded to an external surface of a first end of the applicator.
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
A61H 35/02 - Baths for specific parts of the body, e.g. breast douches for the eyes
A61K 9/00 - Medicinal preparations characterised by special physical form
74.
Compositions, kits and methods for ameliorating oculoplastic post-procedural effects
A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/085 - Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Eyelid cleansers; [ cosmetics and cosmetic preparations for the eyes; ] cosmetic preparations for skin care around the eyelids; cosmetic preparations for eyelid skin care Pharmaceutical preparations for the treatment of eye diseases and conditions; anti-bacterial eye cleansers; anti-inflammatory eye cleansers; medicated skin care preparations around the eyelids; medicated skin care preparations for the eyelids
77.
Compositions, kits and methods for maintaining eyelid hygiene
An ophthalmic composition comprising: (a) a mixture of antimicrobial agents that substantially eliminates at least seven bacterial strains, wherein the mixture includes polyaminopropyl biguanide, a 1,2-glycol, and a sphingoid lipid; (b) a blended surfactant solution that maintains the first ophthalmic composition at a pH between 5.5 and 7.5, wherein the blended surfactant solution has a foaming ability; (c) a foam stabilizer; and (d) a moisturizer.
A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.
Compositions and methods for cleansing the eyelid and treating an ocular condition are disclosed herein. A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.
Compositions and methods for cleansing the eyelid and treating an ocular condition are disclosed herein. A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Compositions and methods for cleansing the eyelid and treating an ocular condition are disclosed herein. A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Medicated lid scrub with foaming eyelid cleansers, medicated
pre-moistened wipes, and medicated facial cleansers, namely,
foams, solutions, creams, gels, lotions and ointments for
eyelid cleansing and removal of encrustation and other
foreign matter from the eyelids, eyelashes, and periocular
area.
41 - Education, entertainment, sporting and cultural services
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Online retail store services, catalog ordering service and electronic catalog services featuring ophthalmic goods, cosmetics and pharmaceutical preparations; mail order services featuring ophthalmic goods, cosmetics and pharmaceutical preparations; business consulting services incorporating customized reports and visual materials rendered to the ophthalmic profession Providing training for the purpose of educating consumers and professionals in the field of eye care and health of the eye; providing training on the proper use of ophthalmic solutions and eyelid wipes; development and dissemination of printed educational materials of others in the field of ophthalmology; educational services namely, conducting educational conventions, educational seminars, educational conferences, and educational symposiums in the field of ophthalmology; providing online newsletters in the field of ophthalmology via email Providing medical information in the field of eye care, namely, programs for health of the eye and ophthalmics; providing medical information for the purpose of educating consumers and professionals in the fields of eye care, health of the eye and ophthalmics, and the proper use of ophthalmic solutions and eyelid wipes; providing websites featuring medical information in the fields of eye care, health of the eye and ophthalmics, and the proper use of ophthalmic solutions and eyelid wipes
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Medicated lid scrub with foaming eyelid cleansers for eyelid cleansing and removal of encrustation and other foreign matter from the eyelids, eyelashes, and periocular area; medicated pre-moistened wipes for eyelid cleansing and removal of encrustation and other foreign matter from the eyelids, eyelashes, and periocular area; medicated facial cleansers, namely, foams, solutions, creams, gels, lotions and ointments for eyelid cleansing and removal of encrustation and other foreign matter from the eyelids, eyelashes, and periocular area.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Medicated lid scrub with foaming eyelid cleansers, medicated pre-moistened wipes, and medicated facial cleansers, namely, foams, solutions, creams, gels, lotions and ointments for eyelid cleansing and removal of encrustation and other foreign matter from the eyelids, eyelashes, and periocular area
In one form, a projection frame eyelid heater includes a heating element, a frame, and a plurality of flexible standoffs. The heating element has first and second heat producing areas separated by a distance corresponding to a separation of human eyes and having first and second ends. The heating element produces heat in response to an application of a voltage thereto. The frame includes a left temple attachment portion and a right temple attachment portion each having a respective back portion extending downward and inward. The plurality of flexible standoffs is for attaching the heating element to the frame. In another form, the projection frame eyelid heater is combined with first and second insulated wires having first ends connected to the heating element, and second ends, to form an eye mask system.
Systems, methods, and kits useful for cleansing the eyelids and maintaining eyelid hygiene are disclosed. In one embodiment, a system for treating or cleansing an ocular region is disclosed. The system consists essentially of: (A) a tubular applicator, wherein the applicator comprises: (i) a first chamber and a second chamber; and (ii) a sealable element situated between the first chamber and the second chamber, wherein at least the second chamber is substantially pre-filled with an ocular composition, and (B) a dispenser, wherein the dispenser is bonded to an external surface of a first end of the applicator.
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
A61H 35/02 - Baths for specific parts of the body, e.g. breast douches for the eyes
A61K 9/00 - Medicinal preparations characterised by special physical form
88.
SYSTEMS, METHODS, AND KITS FOR CLEANSING AN OCULAR REGION
Systems, methods, and kits useful for cleansing the eyelids and maintaining eyelid hygiene are disclosed. In one embodiment, a system for treating or cleansing an ocular region is disclosed. The system consists essentially of: (A) a tubular applicator, wherein the applicator comprises: (i) a first chamber and a second chamber; and (ii) a sealable element situated between the first chamber and the second chamber, wherein at least the second chamber is substantially pre-filled with an ocular composition, and (B) a dispenser, wherein the dispenser is bonded to an external surface of a first end of the applicator.
A45D 40/26 - Appliances specially adapted for applying pasty paint, e.g. using roller, using a ball
A61K 8/02 - Cosmetics or similar toiletry preparations characterised by special physical form
A61K 9/00 - Medicinal preparations characterised by special physical form
B65B 9/10 - Enclosing successive articles or quantities of material, in preformed tubular webs, or in webs formed into tubes around filling nozzles, e.g. extruded tubular webs
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Body and beauty care cosmetics; soaps including hand soaps;
hair care preparations including hair lotions; facial scrub,
namely, eyelid scrub; foaming facial cleansers, namely,
eyelid cleansers; disposable wipes impregnated with
cleansing compounds for use on eyelids; facial cleansers,
namely, foams, creams, gels, lotions and balms for eyelid
and eyelash cleansing. Sanitary sterilizing preparations; ophthalmic lubricants in
the forms of gels, solutions, drops, creams, and ointments;
eye drops; medicated facial cleansers, namely, medicated
eyelid scrub; medicated facial cleansers, namely, medicated
lid scrub with foaming eyelid cleanser; medicated ointments
for treating dermatological conditions of the eyelids;
contact lens solution; eye patches for medical purposes,
namely, warm eye compresses and therapeutic eye care pads;
oral nutritional supplements for the support of dry eyes;
medicated pre-moistened wipes; medicated facial cleansers,
namely, foams, solutions, creams, gels, lotions and
ointments for eyelid cleansing and removal of encrustation
and other foreign matter from the eyelids, eyelashes, and
periocular area.
90.
Compositions, kits, and methods for ameliorating oculoplastic post-procedural effects
Embodiments of the invention are directed to compositions, kits and methods for minimizing unsightly post-procedural effects associated with an oculoplastic procedure. The composition can include escin, arnica and phytonadione in a pharmacologically acceptable carrier.
A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/085 - Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Sanitary sterilizing preparations; ophthalmic lubricants in
the forms of gels, solutions, drops, creams, and ointments;
eye drops; medicated facial cleansers, namely, medicated
eyelid scrub; medicated facial cleansers, namely, medicated
lid scrub with foaming eyelid cleanser; medicated ointments
for treating dermatological conditions of the eyelids;
contact lens solution; eye patches for medical purposes,
namely, warm eye compresses and therapeutic eye care pads;
oral nutritional supplements for the support of dry eyes;
medicated pre-moistened wipes; medicated facial cleansers,
namely, foams, solutions, creams, gels, lotions and
ointments for eyelid cleansing and removal of encrustation
and other foreign matter from the eyelids, eyelashes, and
periocular area.
An ocular composition consisting essentially of purified water, PEG-80 sorbitan laurate, sodium trideceth sulfate, PEG-150 distearate, sodium lauroamphoacetate, cocamidopropyl hydroxysultaine, sodium laureth-13 carboxylate, sodium chloride, PEG-15 cocopolyamine, polyhexamethylene biguanide, potassium sorbate, 1,2 hexanediol, and caprylyl glycol. The composition can be applied to a fabric pad for use as an eyelid cleanser, where the fabric pad is pre-moistened with the composition and packaged for use. The composition may also be used in an eyelid treatment kit for convenient combination treatments to improve overall eyelid hygiene and adjunctive eyelid therapy.
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
A61K 8/18 - Cosmetics or similar toiletry preparations characterised by the composition
An ocular composition consisting essentially of purified water, PEG-80 sorbitan laurate, sodium trideceth sulfate, PEG-150 distearate, sodium lauroamphoacetate, cocamidopropyl hydroxysultaine, sodium laureth-13 carboxylate, sodium chloride, PEG-15 cocopolyamine, polyhexamethylene biguanide, potassium sorbate, 1,2 hexanediol, and caprylyl glycol. The composition can be applied to a fabric pad for use as an eyelid cleanser, where the fabric pad is pre-moistened with the composition and packaged for use. The composition may also be used in an eyelid treatment kit for convenient combination treatments to improve overall eyelid hygiene and adjunctive eyelid therapy.
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
An ocular composition consisting essentially of purified water, PEG-80 sorbitan laurate, sodium trideceth sulfate, PEG-150 distearate, sodium lauroamphoacetate, cocamidopropyl hydroxysultaine, sodium laureth-13 carboxylate, sodium chloride, PEG-15 cocopolyamine, polyhexamethylene biguanide, potassium sorbate, 1,2 hexanediol, and caprylyl glycol. The composition can be applied to a fabric pad for use as an eyelid cleanser, where the fabric pad is pre-moistened with the composition and packaged for use. The composition may also be used in an eyelid treatment kit for convenient combination treatments to improve overall eyelid hygiene and adjunctive eyelid therapy.
